GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Karo Pharma AB (OTCPK:KARBF) » Definitions » Cyclically Adjusted PB Ratio

Karo Pharma AB (Karo Pharma AB) Cyclically Adjusted PB Ratio : (As of Jun. 07, 2024)


View and export this data going back to . Start your Free Trial

What is Karo Pharma AB Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Karo Pharma AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Karo Pharma AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karo Pharma AB Cyclically Adjusted PB Ratio Chart

Karo Pharma AB Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Karo Pharma AB Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Karo Pharma AB's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Karo Pharma AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Karo Pharma AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Karo Pharma AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Karo Pharma AB's Cyclically Adjusted PB Ratio falls into.



Karo Pharma AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Karo Pharma AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2022 is calculated as:

For example, Karo Pharma AB's adjusted Book Value per Share data for the three months ended in Jun. 2022 was:

Adj_Book=Book Value per Share/CPI of Jun. 2022 (Change)*Current CPI (Jun. 2022)
=3.011/118.3836*118.3836
=3.011

Current CPI (Jun. 2022) = 118.3836.

Karo Pharma AB Quarterly Data

Book Value per Share CPI Adj_Book
201206 0.165 100.352 0.195
201209 0.120 100.467 0.141
201212 0.209 100.403 0.246
201303 0.133 100.416 0.157
201306 0.076 100.206 0.090
201309 0.102 100.544 0.120
201312 0.089 100.541 0.105
201403 0.043 99.788 0.051
201406 0.207 100.432 0.244
201409 0.168 100.161 0.199
201412 0.102 100.225 0.120
201503 0.057 99.950 0.068
201506 0.060 99.995 0.071
201509 0.437 100.228 0.516
201512 0.615 100.276 0.726
201603 0.631 100.751 0.741
201606 0.843 101.019 0.988
201609 0.825 101.138 0.966
201612 0.874 102.022 1.014
201703 1.207 102.022 1.401
201706 1.192 102.752 1.373
201709 1.306 103.279 1.497
201712 1.922 103.793 2.192
201803 1.737 103.962 1.978
201806 2.365 104.875 2.670
201809 2.324 105.679 2.603
201812 2.310 105.912 2.582
201903 2.303 105.886 2.575
201906 2.280 106.742 2.529
201909 2.332 107.214 2.575
201912 2.663 107.766 2.925
202003 2.529 106.563 2.810
202006 2.699 107.498 2.972
202009 2.830 107.635 3.113
202012 2.994 108.296 3.273
202103 3.028 108.360 3.308
202106 3.053 108.928 3.318
202109 2.998 110.338 3.217
202112 2.816 112.486 2.964
202206 3.011 118.384 3.011

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Karo Pharma AB  (OTCPK:KARBF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Karo Pharma AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Karo Pharma AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Karo Pharma AB (Karo Pharma AB) Business Description

Traded in Other Exchanges
N/A
Address
Klara Norra Kyrkogata 33, Stockholm, SWE, 111 22
Karo Pharma AB is a healthcare corporation. It is engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of development and sale of products to pharmacies, digital distribution channels and food stores. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.

Karo Pharma AB (Karo Pharma AB) Headlines

From GuruFocus

Avista Capital Partners To Sell Trimb To Karo Pharma

By PRNewswire PRNewswire 06-25-2019